[Justifications for formula supplementation in low-risk newborns at a Baby-Friendly Hospital]

Cynthia de Almeida Brandão Meirelles1, Maria Inês do Couto Oliveira, Rosane Reis de Mello

  • 1Universidade do Grande Rio, Duque de Caxias, Brasil.

Cadernos De Saude Publica
|September 25, 2008
PubMed

Insights

Many newborns in Baby-Friendly Hospitals receive formula, often unnecessarily. This study found only 9% of formula supplementation allegations were justified, highlighting a need for improved adherence to breastfeeding guidelines.

Area of Science:

  • Neonatal Nutrition
  • Public Health
  • Lactation Studies

Context:

  • The Baby-Friendly Hospital Initiative (BFHI) promotes exclusive breastfeeding.
  • Rooming-in policies are standard in BFHI facilities.
  • Formula supplementation is discouraged unless medically indicated.

Purpose:

  • To determine the prevalence of formula supplementation in rooming-in newborns at a BFHI.
  • To investigate the alleged reasons for formula supplementation.
  • To assess the justification of these reasons against BFHI guidelines.

Summary:

  • A study of 300 formula-supplemented, rooming-in newborns in Brazil found a 33.3% supplementation prevalence.
  • Common allegations included hypogalactia (36.8%) and hypoglycemia risk (21.1%).
  • Cesarean section delivery increased supplementation risk (RP=2.1). Only 9% of allegations were justified.

Impact:

  • Highlights potential over-supplementation in BFHI settings.
  • Suggests a need for enhanced training on BFHI guidelines for healthcare providers.
  • Informs strategies to improve exclusive breastfeeding rates and infant health outcomes.

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube through...
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...